This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Universitatsklinikum Hamburg-Eppendorf. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Reinhard Wähler: Innovator in Gene Therapy
Introduction
Reinhard Wähler is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of gene therapy, particularly through his innovative work on viral vectors. His research focuses on the development of therapeutic solutions for treating tumors.
Latest Patents
Wähler holds a patent for "Viral vectors and the use of the same for gene therapy." This invention relates to viral vectors that comprise nucleic acid sequences coding for single chain interleukin-12 (scIL-12) and a costimulator protein. The patent outlines the use of these vectors for gene therapy, especially in the treatment of tumors. Additionally, it includes adenoviral vectors containing nucleic acid sequences with a sequence homology of at least 90% in relation to specific sequences.
Career Highlights
Reinhard Wähler is affiliated with Universitätsklinikum Hamburg-Eppendorf, where he conducts his research and development work. His expertise in gene therapy and viral vectors has positioned him as a key figure in the medical research community.
Collaborations
Wähler collaborates with Frank Schnieders, contributing to advancements in their shared field of study. Their partnership enhances the potential for innovative solutions in gene therapy.
Conclusion
Reinhard Wähler's work in gene therapy exemplifies the impact of innovative research on medical treatments. His contributions through patents and collaborations continue to pave the way for advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile